text: << Desvenlafaxine succinate >> (DVS) is a recently introduced antagonist of the human norepinephrine and serotonin transporters (hNET and [[ hSERT ]], respectively), currently in clinical development for use in the treatment of major depressive disorder and vasomotor symptoms associated with menopause.